Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 29:9:602195.
doi: 10.3389/fped.2021.602195. eCollection 2021.

miRNAs and Leukotrienes in Respiratory Syncytial Virus Infection

Affiliations
Review

miRNAs and Leukotrienes in Respiratory Syncytial Virus Infection

Zhi Liu et al. Front Pediatr. .

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that regulate posttranscription by binding to 3'-untranslated regions of target mRNAs. Recent functional studies have elucidated mechanisms that miRNAs regulate leukotriene synthesis by perturbing arachidonic acid metabolism. Both microarrays and high-throughput sequencing revealed distinct differential expression of miRNAs in children with respiratory syncytial virus (RSV) infection compared with healthy controls. Abnormal miRNA expression may contribute to higher leukotriene levels, which is associated with airway hyperreactivity. Targeting miRNAs may benefit to restore the homeostasis of inflammatory reaction and provide new strategies to alleviate airway hyperreactivity induced by RSV. In this article, we provide an overview of the current knowledge about miRNAs modulating leukotrienes through regulation of arachidonic acid metabolism with a special focus on miRNAs aberrantly expressed in children with RSV infection.

Keywords: arachidonic acid; children; leukotriene; microRNA; respiratory syncytial virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
miRNAs were validated to modulate the metabolism of arachidonic acid (AA). In airway epithelial cells, RSVs are recognized by PAMPs such as TLRs, which subsequently activate signal pathways like NF-κB and affect the expression profile of miRNAs. MiRNAs regulate leukotriene synthesis by modulating AA metabolism, which mainly includes the LOX pathway and COX pathway. Thereinto, miR-219-2 can inhibit several enzymes such as cPLA2, 5-LOX, and LTA4H. Some miRNAs have been confirmed to inhibit the expression of 5-LOX, such as let-7, miR-19a, and miR-125. In addition, miR-146a, miR-135a, and miR-199 can regulate 5-LOX enzyme activity by downregulating FLAP; let-7 and miR-21 by downregulating p38 MAPK. Interference with these miRNAs may contribute to the consistently overexpressed leukotrienes. MiRNAs such as miR-16, miR-26, miR-30a, miR-143, and miR-146a may lead to the conversion of more AA to leukotriene by inhibiting the COX pathway. Besides, overexpression of miRNAs like miR-101 and miR-106a can suppress 12-LOX/15-LOX, which could disrupt the balance between pro-inflammatory and inflammation-resolving mediators. Among these miRNAs, let-7, miR-16-5p, miR-19a, miR-21, miR-26b, miR-30a-5p, miR-125a, miR-143, and miR-146a have been found abnormal expression in RSV infection.

Similar articles

Cited by

References

    1. Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. (2017) 390:946–58. 10.1016/S0140-6736(17)30938-8 - DOI - PMC - PubMed
    1. Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev. (2017) 30:277–319. 10.1128/CMR.00010-16 - DOI - PMC - PubMed
    1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. (2003) 289:179–86. 10.1001/jama.289.2.179 - DOI - PubMed
    1. Friedman D, Fryzek J, Jiang X, Bloomfield A, Ambrose CS, Wong PC. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS ONE. (2017) 12:e0172512. 10.1371/journal.pone.0172512 - DOI - PMC - PubMed
    1. Bennett MV, McLaurin K, Ambrose C, Lee HC. Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations. PLoS ONE. (2018) 13:e0205399. 10.1371/journal.pone.0205399 - DOI - PMC - PubMed

LinkOut - more resources